Ticker League

EBITDA Margin for Medtronic (MDT) 1986-2026

As of · Reported

Metric

TTM

26.7%

YoY change

-0.51pp

Trough year (FY1989)

23.5%

Peak year (FY1998)

48.3%

EBITDA Margin history chart for Medtronic (MDT) from 2017 to 2026

Latest: 27.0%

EBITDA Margin change chart for Medtronic (MDT) from 2017 to 2026

Latest: -0.51pp

EBITDA Margin history table for Medtronic (MDT) from 1986 to 2026

  • FY202627.0%-0.51pp
  • FY202527.5%+2.14pp
  • FY202425.3%-2.50pp
  • FY202327.9%+0.15pp
  • FY202227.7%+2.72pp
  • FY202125.0%-2.04pp
  • FY202027.0%-3.42pp
  • FY201930.4%-1.16pp
  • FY201831.6%+2.61pp
  • FY201729.0%-0.64pp
  • FY201629.6%+2.69pp
  • FY201526.9%-2.08pp
  • FY201429.0%-3.88pp
  • FY201332.9%-0.02pp
  • FY201232.9%+2.05pp
  • FY201130.9%-1.49pp
  • FY201032.4%+8.31pp
  • FY200924.0%-3.90pp
  • FY200827.9%-7.19pp
  • FY200735.1%-2.49pp
  • FY200637.6%-1.23pp
  • FY200538.9%-1.02pp
  • FY200439.9%-0.06pp
  • FY200339.9%+1.28pp
  • FY200238.7%-0.52pp
  • FY200139.2%+0.75pp
  • FY200038.4%+0.23pp
  • FY199938.2%-10.10pp
  • FY199848.3%+5.43pp
  • FY199742.9%+8.39pp
  • FY199634.5%+3.33pp
  • FY199531.2%+1.59pp
  • FY199429.6%+2.11pp
  • FY199327.5%+1.51pp
  • FY199225.9%+1.19pp
  • FY199124.8%+0.33pp
  • FY199024.4%+0.93pp
  • FY198923.5%-0.85pp
  • FY198824.4%-1.96pp
  • FY198726.3%+1.59pp
  • FY198624.7%—

EBITDA Margin values are taken from Medtronic's reported income statements (interim 6-K and annual 20-F filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About EBITDA Margin at Medtronic (MDT)

According to Medtronic's latest reported financial statements, the company's latest reported EBITDA margin is 26.7%. EBITDA margin is EBITDA divided by revenue — earnings before interest, taxes, depreciation, and amortization as a percentage of sales. By stripping out non-cash charges and capital-structure effects, it approximates operating cash profitability and is widely used to compare companies with different asset bases and leverage.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

Medtronic (MDT) most recent annual EBITDA margin stands at 26.97% (2026) – contracted 0.5 percentage points year-over-year.

1998 marks the peak EBITDA margin at 48.30%, with the historical low of 23.50% recorded in 1989.

Medtronic EBITDA Margin by Year

Medtronic EBITDA Margin 2026: 27.0%

In 2026, Medtronic reported EBITDA margin of 26.97%, contracted 0.5 percentage points from 2025.

Medtronic EBITDA Margin 2025: 27.5%

Medtronic EBITDA margin in 2025 was 27.49%, expanded 2.1 percentage points from 2024.

Medtronic EBITDA Margin 2024: 25.3%

2024's EBITDA margin for Medtronic came in at 25.35%, contracted 2.5 percentage points from 2023.

Medtronic EBITDA Margin 2023: 27.9%

Medtronic posted EBITDA margin of 27.85% in 2023, expanded 0.2 percentage points from 2022.

Medtronic EBITDA Margin 2022: 27.7%

Medtronic EBITDA margin in 2022 was 27.70%.

See more financial history for Medtronic (MDT).

Sector peers by EBITDA Margin

Healthcare peers of Medtronic (MDT), ranked by their latest EBITDA margin

Frequently asked questions

Medtronic (MDT) Key Financials

Charts, filings, and peer comparison for every metric

Operations

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview
Capital Return

How this company returns cash to shareholders — buybacks, dividends, and stock splits.